Pathologists' findings in toxicity studies frequently form the cornerstone for the assessment of safety of a compound with all its attendant scientific and economic implications. This is particularly evident in the evaluation of the carcinogenic potential of chemicals.
The differentiation between benign and malignant neoplasia based on cytologic and histologic features are somewhat subjective and often pcrplcxing. As pointed out by Galli (Science, 226, 1984) , criteria such as hyperchomatism, hypercellularity, apparent local invasion, and high mitotic indices arc features associated with malignancy, but their reliability varies with tumor type, organ, and species. Metastases still remain the unequivocal indicator of malignancy.
Similar frustrations may occur in the distinction between hyperplastic, prcneoplastic (whatever the term means), and benign neoplastic Icsions. Proliferative changes in epithelial and mesenchymal tissues can result from such factors as local irritation, necrosis, or uneven response to physiologic states. i.c., hormonal imbalance or sensitivity. For example, proliferative lesions of the urothelium or of hepatocytes may progress to frank neoplasia or may regress once the reactive stimulus is removed. The current state of our knoivlcdie concerning the biology of such lesions in most instances is insufficient to identify which lesions will progress to neoplasia on morphologic characteristics alone.
In rodents, cspkcially the rat, the biologic behavior of certain neoplasia seems not to follow a predictive course based exclusively on morphologic criteria. Kodent tumor nomenclature has been derived largely from human pathology and while often appropriate, may be misleading in certain instances regarding biologic behavior in different species. For example, mammary carcinomas are frequently diagnosed in aged female rats; hoivever, the frequency of metastases is very low in spontaneously occurring lesions, suggcsting that the natural history of these tumors is quite different from that in humans.
Unfortunately. there has been only limited information generated regarding fine structure, antigen expression, and biochemical characterization of animal tumors. The increased utilizaton of electron microscopy, cytochemistry, immunocytochemistry, and biochemistry to characterize proliferative lesions in rodents along with more definitive assessment of their biologic behavior should provide much needed assistance for pathologists in the determination of appropriate classifications and interpretation of tumors in the future.
Undoubtedly, there will continue to be honest debate among pathologists concerning classification of rodent or laboratory animal tumors. However, it is becoming increasingly evident that more than sfantlard morphologic criteria are needed to assess the true nature and significance of proliferative lesions in chronic rodent studies. 
